MedAccess (original) (raw)

About DBpedia

MedAccess is a social finance company based in London. It is capitalized with $200 million, enabling it to provide loans and financial guarantees designed to increase access to health products, including vaccines, therapeutics, and diagnostic tests, for patients in low- and middle-income countries. The company had provided six guarantees by the end of 2021. The guarantees support access to health products that tackle COVID-19, HIV, malaria, syphilis, and tuberculosis, particularly in Africa and South Asia.

Property Value
dbo:abstract MedAccess is a social finance company based in London. It is capitalized with $200 million, enabling it to provide loans and financial guarantees designed to increase access to health products, including vaccines, therapeutics, and diagnostic tests, for patients in low- and middle-income countries. MedAccess’s finance reduces market risks facing manufacturers and procurers. One of its most commonly used tools is a volume guarantee. In return for guaranteed sales, manufacturers provide long-term price reductions and assurances of supply security. MedAccess’s guarantees also aim to strengthen markets. Patients benefit from lower costs and more availability as new manufacturers enter the markets while existing manufacturers reduce their prices to compete for market share. The company had provided six guarantees by the end of 2021. The guarantees support access to health products that tackle COVID-19, HIV, malaria, syphilis, and tuberculosis, particularly in Africa and South Asia. (en)
dbo:foundingYear 2017-01-01 (xsd:gYear)
dbo:numberOfEmployees 22 (xsd:nonNegativeInteger)
dbo:wikiPageID 70309372 (xsd:integer)
dbo:wikiPageLength 14373 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID 1118344733 (xsd:integer)
dbo:wikiPageWikiLink dbr:Bill_&_Melinda_Gates_Foundation dbr:Department_for_International_Development dbr:Developing_country dbr:Hologic dbr:Vaccine dbr:Infant_mortality dbr:Innovative_Vector_Control_Consortium dbr:Innovative_financing dbr:Insecticide dbr:Sustainable_Development_Goals dbr:GAVI dbr:GlaxoSmithKline dbr:Miscarriage dbr:Malaria dbr:Stillbirth dbr:Clinton_Health_Access_Initiative dbr:Medical_test dbr:BASF dbr:COVAX dbr:COVID-19 dbr:Tuberculosis dbr:HIV dbr:Latent_tuberculosis dbr:Loan dbr:Loan_guarantee dbr:Foreign,_Commonwealth_and_Development_Office dbr:British_International_Investment dbr:The_Global_Fund_to_Fight_AIDS,_Tuberculosis_and_Malaria dbr:Pyrethroid dbc:Social_finance dbr:Chlorfenapyr dbr:Syphilis dbr:President's_Emergency_Plan_for_AIDS_Relief dbr:Pneumonia dbr:World_Health_Organization dbr:The_Children's_Investment_Fund_Foundation dbr:Social_finance dbr:Working_capital dbr:RTS,S dbr:Mosquito_net dbr:Unitaid
dbp:founded 2017 (xsd:integer)
dbp:hqLocation London, UK (en)
dbp:industry Global health, development finance (en)
dbp:keyPeople Nigel Keen , Michael Anderson (en)
dbp:name MedAccess Guarantee Ltd (en)
dbp:numEmployees 22 (xsd:integer)
dbp:wikiPageUsesTemplate dbt:Advert dbt:Infobox_company dbt:Multiple_issues dbt:Orphan dbt:URL
dcterms:subject dbc:Social_finance
rdf:type owl:Thing dbo:Company schema:Organization dul:Agent dul:SocialPerson dbo:Agent wikidata:Q24229398 wikidata:Q43229 wikidata:Q4830453 dbo:Organisation
rdfs:comment MedAccess is a social finance company based in London. It is capitalized with $200 million, enabling it to provide loans and financial guarantees designed to increase access to health products, including vaccines, therapeutics, and diagnostic tests, for patients in low- and middle-income countries. The company had provided six guarantees by the end of 2021. The guarantees support access to health products that tackle COVID-19, HIV, malaria, syphilis, and tuberculosis, particularly in Africa and South Asia. (en)
rdfs:label MedAccess (en)
owl:sameAs wikidata:MedAccess https://global.dbpedia.org/id/GXz91
prov:wasDerivedFrom wikipedia-en:MedAccess?oldid=1118344733&ns=0
foaf:isPrimaryTopicOf wikipedia-en:MedAccess
foaf:name MedAccess Guarantee Ltd (en)
is foaf:primaryTopic of wikipedia-en:MedAccess